Inve India ▾
BABALAMINES

Balaji Amines Q4 FY26 results (Jan–Mar 2026) and concall

Chemicals · Concall AI · Call held 18 May 2026

Balaji Amines reported a strong Q4 FY26 with significant revenue and profit growth, driven by improved margins and operational efficiencies. The company made substantial progress on its strategic expansion projects, including DME, NMM, ACN, and Balaji Specialty Chemicals, which are expected to drive future growth. Despite challenges like geopolitical impacts and raw material volatility, management expressed confidence in maintaining profitability and achieving volume growth targets.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

Q4 FY26: revenue up 11.9%, net profit up 62.5% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue347 313 353 358 341 −2%331 +6%395 +12%
EBITDA61 46 60 55 60 −2%57 +24%94 +57%
Net profit41 31 40 37 37 −10%31 +0%65 +63%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.